Chip Clark

Chip Clark is the current President & CEO at Genocea Biosciences. Chip has over 25 years of experience in the pharmaceutical industry.

Clark started their career at SmithKline Beecham in 1990, where they held various positions over a 10-year period. In 2000, they joined Care Capital as a Principal. Chip then moved to Vanda Pharmaceuticals in 2004, where they served as CBO until 2010.

Clark has been with Genocea Biosciences since 2010. Under their leadership, the company has developed innovative new vaccines and treatments for infectious diseases.

Chip Clark attended Harvard University for their BA and then The Wharton School for their MBA.

Some direct reports include Raymond D. Stapleton - Chief Technology Officer, Tom Davis - Chief Medical Officer, and Girish Aakalu - Chief Business Officer.